Warren, Andrew D.
Li, Qi
Schwab, Kristin
McKaig, Brenna
Goldstein, Alexa N.
Greenberg, Steven M.
Viswanathan, Anand
Anderson, Christopher
Gurol, M. Edip
Patel, Aman
Goldstein, Joshua N.
Article History
Received: 3 June 2022
Accepted: 19 August 2022
First Online: 15 September 2022
Declarations
:
: The research in this manuscript adhered to ethical guidelines and the Massachusetts General Hospital IRB. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. Written informed consent was obtained from all participants for that data which consisted of more than standard-of-care clinical data obtained from medical records. The Massachusetts General Hospital IRB waived the need for informed consent for the obtaining of clinical care data from medical records.
: Not applicable.
: Dr. Goldstein reports having received research and consulting support from CSL Behring, Octapharma, Takeda, Alexion, Pfizer, NControl, and Cayuga. Dr. Anderson receives sponsored research support from the National Institute of Health, American Heart Association, Massachusetts General Hospital, and Bayer AG and has consulted for ApoPharma, Inc. All research support and potential conflicts of interest have been disclosed. The other authors declare that they have no competing interests.